Merck agreed to pay $9.2 billion to purchase Cidara Therapeutics, looking to cash in on the firm's experimental flu treatment.
A startup’s entry into prediction market trading is raising fresh questions about the involvement of NBA owners in sports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback